Copyright: ©Author(s) 2026.
World J Clin Oncol. Jun 24, 2026; 17(6): 117812
Published online Jun 24, 2026. doi: 10.5306/wjco.117812
Published online Jun 24, 2026. doi: 10.5306/wjco.117812
Table 6 Baseline characteristics of patients with and without preoperative drug withdrawal
| Indicator with | Withdrawal group (n = 90) | Non-withdrawal group (n = 12) | P value |
| Age (years) | 48.5 ± 10.2 | 50.1 ± 9.8 | 0.612 |
| Gender (male/female) | 36/54 | 4/8 | 0.735 |
| Tumor diameter (cm) | 3.5 ± 1.3 | 3.8 ± 1.2 | 0.478 |
| Hypertension duration (years) | 4.2 ± 1.8 | 4.5 ± 1.9 | 0.631 |
| RAAS hormones (pg/mL) | 146.3 ± 38.5 | 152.7 ± 40.2 | 0.524 |
| Adrenal medullary hormones (pg/mL) | 96.8 ± 24.1 | 101.5 ± 25.3 | 0.497 |
| Surgical approach (laparoscopy/open) | 72/18 | 8/4 | 0.689 |
- Citation: Du ZG, Wu YY, Homyy T, Zhao WQ, Minsler T, Tekosiv S, Zhang T, Song C, Tui TL, Shi ST, Tan HJ, Jan S, Deng SJ, Qiu LM, Su TX, Teisy S, Zhuang ZX, Xie XJ, Qiu TX, Xiong ZD, Lang TX, Zhen XL, Qin JX, Zheng XB, Teriguezs X, Fie T, Hasly G, Duan CK, Deng CH. Factors influencing postoperative of hypertension remission in adrenal cavernous hemangioma: A multicenter retrospective cohort study. World J Clin Oncol 2026; 17(6): 117812
- URL: https://www.wjgnet.com/2218-4333/full/v17/i6/117812.htm
- DOI: https://dx.doi.org/10.5306/wjco.117812